Dosimetric benefit of an adaptive treatment by means of plan selection for rectal cancer patients in both short and long course radiation therapy

Table 1 Patient characteristics

nr	Age	Sex	Tumor stage	Treatment scheme	Chemo	GTV location	Surgery	Bladder volume cm³ planning CT	Upper mesorectum volume cm³ planning CT	Upper mesorectum length mm planning CT	Available margins (mm)			Average bladder volume CBCT relative to planning CT	Average upper mesorectum volume CBCT relative to planning CT
1	65	M	cT3N1M0	5 × 5 Gy	N	proximal	LAR	185	259	55	−15	0	15	1.13	1.03
2	70	F	cT3N0M0	5 × 5 Gy	N	mid	LAR	558	143	60	0	15	25	0.66	1.05
3	63	M	cT4N1M0	5 × 5 Gy	Y	distal	ns	203	269	60	−15	0	15	0.84	1.06
4	71	M	cT3N1M0	5 × 5 Gy	N	mid	LAR	622	184	86	0	15	25	0.70	1.14
5	74	M	cT3N0M0	5 × 5 Gy	N	proximal	LAR	557	226	65	0	15	25	0.57	1.06
6	56	F	cT3N1M0	5 × 5 Gy	N	mid	LAR	135	156	41	−15	0	15	0.42	1.02
7	73	M	cT3N2M1	5 × 5 Gy	Y	proximal	LAR	160	357	71	0	15	25	1.02	0.97
8	70	M	cT3N2M0	5 × 5 Gy	N	distal	APR	295	244	65	0	15	25	0.59	1.03
9	40	F	cT3N1M0	5 × 5 Gy	N	mid	LAR	941	131	57	0	15	25	0.52	1.25
10	78	M	cT4N1M0	5 × 5 Gy	N	rectosigmoid	LAR	613	289	70	0	15	25	0.33	1.06
11	71	F	cT3N1M0	25 × 2 Gy	Y	proximal	LAR	791	393	80	−15	0	15	0.63	0.71
12	66	M	cT3N2M0	25 × 2 Gy	Y	mid	LAR	150	185	46	−15	0	15	1.05	0.9
13	64	F	cT3N2M0	25 × 2 Gy	Y	distal	APR	403	223	65	0	15	25	0.31	0.95
14	65	M	cT3N2M0	25 × 2 Gy	Y	proximal	LAR	446	309	65	0	15	25	0.65	1.09
15	55	F	cT4N0M0	25 × 2 Gy	Y	distal	LAR	595	186	67	0	15	25	0.42	0.91
16	59	M	cT3N0M0	25 × 2 Gy	Y	mid	LAR	166	170	52	−15	0	15	1.27	1.00
17	72	M	cT3N2M0	25 × 2 Gy	Y	proximal	LAR	420	373	85	0	15	25	0.65	1.05
18	69	F	cT4N1M0	25 × 2 Gy	Y	mid	LAR	511	442	97	0	15	25	0.79	0.99
19	77	M	cT3N2M0	25 × 2 Gy	Y	distal	ns	456	128	58	0	15	25	0.55	1.10
20	60	M	cT3N2M0	25 × 2 Gy	Y	distal	ns	392	261	67	−15	0	15	0.75	0.92

ISSN: 1748-717X